Since you are back Mak. What do you take from SS answer to the question at 31:30 on does he see significant increasing revenues each quarter this year and moving forward? The answer a flat out No. Given you've previously stated your re-evaluation of the stock if revenues didn't increase significantly by mid to end year.
Seems us shareholders research has got it wrong again and any perceived increase in sales by P&G of our tech won't result in significant revenue any time soon. So much for the the BOD statement of a trickle turning into a flood.
- Forums
- ASX - By Stock
- WFL
- Well done Steve Schapera
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

Well done Steve Schapera, page-90
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online